<DOC>
	<DOC>NCT01390857</DOC>
	<brief_summary>The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox</brief_summary>
	<brief_title>Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)</brief_title>
	<detailed_description />
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Pediatric patients with chickenpox (aged less than 15 years old). Patients with a history of hypersensitivity to the ingredients of valaciclovir or acyclovir.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>